Delivery Order SPE2DB24D1205-SPE2DB24FCQRZ
- Not listed
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of the medication XCOPRI 100 MG TABLET 30S. The contract has a firm fixed price of $1,178.96 and a completion date of April 21, 2025. This award is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999.00 that AmerisourceBergen holds with the DLA Troop Support Medical, which provides a comprehensive global pharmaceutical...
- This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of XCOPRI 200 MG TABLET 30S, a prescription medication. The contract has a ceiling value of $1,836.63 and a period of performance through July 2, 2025. There is no set-aside designation, indicating this was an open competition. Amerisourcebergen Drug Corp holds a...
- This is a $1,655.46 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of XCOPRI 100 MG TABLET 30S, a pharmaceutical product, with a period of performance through July 23, 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, valued at $999,999,999...
- This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,305.54, is for the supply of the prescription medication XCOPRI 100 MG TABLET 30S. The contract has a firm fixed price pricing type and an ultimate completion date of April 28, 2025. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA...
- This is a $1,768.44 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of XCOPRI 50 MG TABLET 30S, a medication, with a period of performance through May 16, 2025. Amerisourcebergen Drug Corp holds a larger $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which provides a comprehensive global...
- This is a Delivery Order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,357.92, is for the delivery of the drug XCOPRI 100 MG TABLET 30S. The award is part of a larger Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as a primary vehicle for...
- This is a $1,178.96 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of XCOPRI 200 MG TABLET 30S, a specialty medication. This delivery order is part of a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. The IDC serves as a primary vehicle for...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of the prescription medication XCOPRI 200 MG TABLET 30S. The contract has a ceiling value of $1,767.72 and is a firm fixed-price delivery order, with a period of performance through May 5, 2025. The contract is not designated as a set-aside. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop...
- This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of XCOPRI 200 MG TABLET 30S, with a ceiling value of $1,514.24 and a period of performance through May 13, 2025. The contract is not set aside for any particular business size or type. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract...
- This is a $4,540.09 firm-fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of the medication XCOPRI 50 MG TABLET 30S, with a completion date of June 26, 2025. The contract is not set aside and was awarded on June 25, 2025. Amerisourcebergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with the...
- SPE2DB24D1205Indefinite Delivery Contract
- SPE2DB24D1205-SPE2DB24FCQRZDelivery Order
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and supplier to the U.S. federal government. The contract is for the provision of the prescription medication XCOPRI 100 MG TABLET 30S, with a ceiling value of $1,154.12 and a period of performance ending on April 23, 2024. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which operates under the "Amerisourcebergen" name. This contract award is part of a larger Indefinite Delivery Contract (IDC) valued up to $999,999,999.00 that Amerisourcebergen holds with DLA Troop Support Medical, which serves as the primary vehicle for the company to deliver a wide range of pharmaceutical products and medical supplies to DLA facilities supporting the Department of Defense worldwide. The contract does not have a set-aside designation, indicating it was awarded through full and open competition.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.2k | 4/22/24 |